EcoDrugPlus

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSSMAG00000009501
Gene Symbol: GRIA2B
1 Cross references
224 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSSMAG00000014088
Gene Symbol: GRIA4B
2 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSSMAG00000014880
Gene Symbol: GRIN1A
3 Cross references
205 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSSMAG00000013781
Gene Symbol: GRIN2BB
1 Cross references
250 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2ca

Ensembl ID : ENSSMAG00000012597
Gene Symbol: GRIN2CA
2 Cross references
115 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 5

Ensembl ID : ENSSMAG00000008882
Gene Symbol: GRIK5
1 Cross references
232 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSSMAG00000017164
Gene Symbol: GRM2B
3 Cross references
206 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSSMAG00000003434
Gene Symbol: GRM3
3 Cross references
215 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSSMAG00000017570
Gene Symbol: GRM5A
1 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSSMAG00000019258
Gene Symbol: GRM5B
1 Cross references
216 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSSMAG00000012876
Gene Symbol: GLSA
3 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSSMAG00000017795
Gene Symbol: GSK3AA
3 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).